3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
4
Phase 3
3
Phase EARLY_PHASE1
1
Phase 2/3
1
Phase 2
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Leukemia, Myeloid, Acute
24
Breast Neoplasms
15
Sarcoma
9
Myelodysplastic Syndromes
9
Carcinoma, Non-Small-Cell Lung
9
Stomach Neoplasms
8
Multiple Myeloma
7
Leukemia, Myelomonocytic, Chronic
7
Myeloproliferative Disorders
6
Uterine Cervical Neoplasms
5
Lymphoma, Large B-Cell, Diffuse
5
Recurrence
4
Prostatic Neoplasms
4
Neoplasms
4
Melanoma
4
Lung Neoplasms
4
Leukemia, Monocytic, Acute
4
Head and Neck Neoplasms
4
Carcinoma, Hepatocellular
4
Biliary Tract Neoplasms
4
Advanced Solid Tumour
4
Stomatitis
3
Squamous Cell Carcinoma of Head and Neck
3
Ovarian Neoplasms
3
Neuroendocrine Tumors
3
Mucositis
3
Leukemia, Myelomonocytic, Acute
3
Esophageal Squamous Cell Carcinoma
3
Esophageal Neoplasms
3
Cholangiocarcinoma
3
Interventions
Carboplatin
79
Paclitaxel
64
pembrolizumab
63
Cyclophosphamide
47
Capecitabine
34
Doxorubicin
31
Taxes
28
130-nm albumin-bound paclitaxel
28
Albumin-Bound Paclitaxel
27
Gemcitabine
20
atezolizumab
18
Epirubicin
18
Cisplatin
18
Bevacizumab
18
olaparib
17
sacituzumab govitecan
15
Docetaxel
15
eribulin
14
toripalimab
13
durvalumab
13
camrelizumab
13
Drug Therapy
12
apatinib
9
Trastuzumab
9
Radiotherapy
9
Specimen Handling
8
Magnetic Resonance Spectroscopy
8
Biopsy
8
tislelizumab
7
talazoparib
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Triple Negative Breast Neoplasms
×
Injections
×
Clear all
NCT04770272
2026-01-12
neoMono
Palleos Healthcare GmbH
Phase 2
Terminated
442 enrolled
42 charts